Literature DB >> 12679866

Effect of acute hyperglycaemia on selected plasma and urinary cytokine antagonists in Type 1 diabetes mellitus.

T Pelikánová1, R Simková, V Tesar, M Jirsa.   

Abstract

AIMS/HYPOTHESIS: Several cytokines have been implicated in the pathogenesis of diabetic nephropathy. Their ability to generate a biological response in vivo is modulated by specific antagonists and soluble receptors. The aims of the study were firstly, to measure the interleukin 1 receptor antagonist (IL-1ra) and tumour necrosis factor alpha soluble receptors p55 (TNFsr1) and p75 (TNFsr2) in plasma and urine, and secondly to test their response to acutely induced hyperglycaemia in Type 1 diabetes mellitus (DM 1).
METHODS: Plasma concentrations and urinary excretions of IL-1ra, TNFsr1 and TNFsr2 were measured in two 90-min periods of glycaemic clamp-induced normoglycaemia and hyperglycaemia (5 and 12 mmol/l; study 1) and during time-controlled normoglycaemia (5 and 5 mmol/l; study 2) in 20 Type 1 diabetic patients with normal albumin excretion and normal glomerular filtration rate, and in 11 weight-, age- and sex-matched healthy control subjects.
RESULTS: The plasma concentrations of IL-1ra, TNFsr1 and TNFsr2 were comparable in Type 1 diabetic patients and control subjects, and no significant changes during study 1 and study 2 were found. Urinary IL-1ra excretion measured during normoglycaemia was higher in Type 1 diabetic patients compared to control subjects ( p<0.05). In diabetic patients, it decreased in study 1 compared to study 2 ( p<0.05), while it did not change in control subjects. The urinary excretions of TNFsr1 and TNFsr2 during normoglycaemia were comparable in diabetic patients and controls. In diabetic patients, hyperglycaemia decreased TNFsr1 excretion (study 1 vs study 2; p<0.01), while TNFsr1 excretion did not change in control subjects. Hyperglycaemia did not affect TNFsr2 excretion in diabetic patients, while it led to an increase in TNFsr2 excretion in control subjects (study 1 vs study 2; p<0.05). Despite comparable renal haemodynamics, diabetic patients had lower fractional excretion of sodium compared to control subjects ( p<0.01). No significant relationships between cytokine antagonists and renal functions have been found. CONCLUSION/
INTERPRETATION: Type 1 diabetic patients with normal renal haemodynamics are associated with impaired regulation of renal IL-1ra, TNFsr1 and TNFsr2 production with a potential impact on local control of cytokine activity in the kidneys.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12679866     DOI: 10.1007/s00125-003-1069-9

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  10 in total

Review 1.  Switching off renal inflammation by anti-inflammatory mediators: the facts, the promise and the hope.

Authors:  L Baud; B Fouqueray; A Bellocq
Journal:  Kidney Int       Date:  1998-05       Impact factor: 10.612

2.  Soluble TNF alpha receptors are increased in chronic renal insufficiency and hemodialysis and inhibit neutrophil priming by TNF alpha.

Authors:  R Ward; K R McLeish
Journal:  Artif Organs       Date:  1996-05       Impact factor: 3.094

Review 3.  Interaction of metabolic and haemodynamic factors in mediating experimental diabetic nephropathy.

Authors:  M E Cooper
Journal:  Diabetologia       Date:  2001-11       Impact factor: 10.122

4.  Role of soluble receptors for tumor necrosis factor alpha in the development of hypoalbuminemia in hemodialysis patients.

Authors:  Mari Odamaki; Akihiko Kato; Takako Takita; Mitsuyoshi Furuhashi; Yukitaka Maruyama; Katsuhiko Yonemura; Akira Hishida
Journal:  Am J Nephrol       Date:  2002 Jan-Feb       Impact factor: 3.754

5.  Advanced glycation end products-cytokine-nitric oxide sequence pathway in the development of diabetic nephropathy: aminoguanidine ameliorates the overexpression of tumour necrosis factor-alpha and inducible nitric oxide synthase in diabetic rat glomeruli.

Authors:  H Sugimoto; K Shikata; J Wada; S Horiuchi; H Makino
Journal:  Diabetologia       Date:  1999-07       Impact factor: 10.122

Review 6.  Molecular mechanisms of diabetic renal hypertrophy.

Authors:  G Wolf; F N Ziyadeh
Journal:  Kidney Int       Date:  1999-08       Impact factor: 10.612

7.  The mechanism of angiotensin II binding downregulation by high glucose in primary renal proximal tubule cells.

Authors:  Soo Hyun Park; Ho Jae Han
Journal:  Am J Physiol Renal Physiol       Date:  2002-02

8.  sTNFRI and sTNFRII synthesis by fine-needle aspiration biopsy sample cultures is significantly associated with acute rejection in kidney transplantation.

Authors:  J G Oliveira; P Xavier; S M Sampaio; A A Mendes; M Pestana
Journal:  Transplantation       Date:  2001-06-27       Impact factor: 4.939

9.  Plasma and urinary cytokine homeostasis and renal dysfunction during cardiac surgery.

Authors:  S M Gormley; W T McBride; M A Armstrong; I S Young; E McClean; S W MacGowan; G Campalani; T J McMurray
Journal:  Anesthesiology       Date:  2000-11       Impact factor: 7.892

10.  Interleukin-1 receptors and receptor antagonist in haemodialysis.

Authors:  D Donati; D Degiannis; E Mazzola; L Gastaldi; J Raskova; K Raska; G Camussi
Journal:  Nephrol Dial Transplant       Date:  1997-01       Impact factor: 5.992

  10 in total
  2 in total

1.  The effect of aliskiren on urinary cytokine/chemokine responses to clamped hyperglycaemia in type 1 diabetes.

Authors:  David Z I Cherney; Heather N Reich; James W Scholey; Denis Daneman; Farid H Mahmud; Ronnie L H Har; Etienne B Sochett
Journal:  Diabetologia       Date:  2013-07-28       Impact factor: 10.122

2.  The acute effect of clamped hyperglycemia on the urinary excretion of inflammatory cytokines/chemokines in uncomplicated type 1 diabetes: a pilot study.

Authors:  David Z I Cherney; James W Scholey; Etienne Sochett; Timothy J Bradley; Heather N Reich
Journal:  Diabetes Care       Date:  2010-09-14       Impact factor: 19.112

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.